Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanner, C. M.
Right arrow Articles by Langston, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanner, C. M.
Right arrow Articles by Langston, J. W.
Related Collections
Right arrow All Medical/Systemic disease
Right arrow Parkinson's disease/Parkinsonism
Right arrow Cohort studies
Neurology 2002;58:581-588
© 2002 American Academy of Neurology

Smoking and Parkinson’s disease in twins

C. M. Tanner, MD, PhD;, S. M. Goldman, MD, MPH;, D. A. Aston, VMD, MPH;, R. Ottman, PhD;, J. Ellenberg, PhD;, R. Mayeux, MSc, MD; and J. W. Langston, MD

From the Parkinson’s Institute (Drs. Tanner, Goldman, Aston, and Langston), Sunnyvale, CA; Gertrude Sergievsky Center (Drs. Ottman and Mayeux), Columbia University College of Physicians and Surgeons, New York, NY; and Westat (Dr. Ellenberg), Rockville, MD.

Address correspondence and reprint requests to Dr. Caroline M. Tanner, Parkinson’s Institute, 1170 Morse Avenue, Sunnyvale, CA 94089; e-mail: ctanner{at}parkinsoninstitute.org

Objective: To test the hypothesis that cigarette smoking protects against the development of PD.

Background: Smoking has been inversely associated with PD in many studies, but whether this reflects a biologic effect on the underlying disease process or merely confounding or selection bias remains uncertain.

Methods: The authors compared smoking histories in male twin pairs identified from the National Academy of Sciences–National Research Council World War II Veteran Twins Cohort. The amount of cigarettes smoked (in pack-years) was collected until the time of PD onset in the affected twin or until the time of death for the unaffected twin, whichever came first. Differences in pack-years smoked until PD onset and until 10 and 20 years before onset were compared using paired t-tests. Comparisons were made overall and stratified by zygosity and concordance for PD. To assess the role of shared environment, correlation for smoking behaviors was compared between pairs concordant and discordant for PD.

Results: Detailed smoking histories were available for 113 twin pairs in which at least one twin had PD (discordant pairs: 43 monozygotic [MZ], 50 dizygotic [DZ]; concordant pairs: 10 MZ, 10 DZ). Within-pair correlation for ever smoking was high in MZ pairs (phi = 0.47, p = 0.001) but not in DZ pairs (phi = 0.007, p = 0.96). In 33 discordant MZ pairs and 39 discordant DZ pairs in which at least one twin had smoked, the twins without PD smoked more than their brothers smoked (32.5 vs 22.7 pack-years, p = 0.026). This was more marked in the MZ pairs (37.1 vs 25.3 pack-years, p = 0.077) than in the DZ pairs (28.6 vs 20.5 pack-years, p = 0.17). A similar relationship was seen when smoking dose was calculated only until 10 years before PD onset, suggesting that the lower dose of smoking in the twin with PD was not the result of early, undiagnosed disease.

Conclusion: Within twin pairs, risk of PD is inversely correlated with the dose (in pack-years) of cigarette smoking. This effect is most pronounced in MZ twins, despite the high correlation for smoking. Because MZ twins are genetically identical and are similar behaviorally, this difference is unlikely to result from either genetic factors or environmental confounders. These results are compatible with a true biologic protective effect of cigarette smoking.




This article has been cited by other articles:


Home page
NeurologyHome page
R. Inzelberg and J. Jankovic
Are Parkinson disease patients protected from some but not all cancers?
Neurology, October 9, 2007; 69(15): 1542 - 1550.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nashmi, C. Xiao, P. Deshpande, S. McKinney, S. R. Grady, P. Whiteaker, Q. Huang, T. McClure-Begley, J. M. Lindstrom, C. Labarca, et al.
Chronic Nicotine Cell Specifically Upregulates Functional {alpha}4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path
J. Neurosci., August 1, 2007; 27(31): 8202 - 8218.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Nakamura and R. H. Edwards
Physiology versus pathology in Parkinson's disease
PNAS, July 17, 2007; 104(29): 11867 - 11868.
[Full Text] [PDF]


Home page
Arch NeurolHome page
B. Ritz, A. Ascherio, H. Checkoway, K. S. Marder, L. M. Nelson, W. A. Rocca, G. W. Ross, D. Strickland, S. K. Van Den Eeden, and J. Gorell
Pooled Analysis of Tobacco Use and Risk of Parkinson Disease
Arch Neurol, July 1, 2007; 64(7): 990 - 997.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C.H. Hawkes
Smoking is a risk factor for multiple sclerosis: a metanalysis
Multiple Sclerosis, June 1, 2007; 13(5): 610 - 615.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. B. Hancock, E. R. Martin, J. M. Stajich, R. Jewett, M. A. Stacy, B. L. Scott, J. M. Vance, and W. K. Scott
Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease
Arch Neurol, April 1, 2007; 64(4): 576 - 580.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C.H. Hawkes
Are multiple sclerosis patients risk-takers?
QJM, December 1, 2005; 98(12): 895 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. L. Fortin, V. M. Nemani, S. M. Voglmaier, M. D. Anthony, T. A. Ryan, and R. H. Edwards
Neural Activity Controls the Synaptic Accumulation of {alpha}-Synuclein
J. Neurosci., November 23, 2005; 25(47): 10913 - 10921.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
A.C. Williams, L.S. Cartwright, and D.B. Ramsden
Parkinson's disease: the first common neurological disease due to auto-intoxication?
QJM, March 1, 2005; 98(3): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. K. Scott, F. Zhang, J. M. Stajich, B. L. Scott, M. A. Stacy, and J. M. Vance
Family-based case-control study of cigarette smoking and Parkinson disease
Neurology, February 8, 2005; 64(3): 442 - 447.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Orb, J. Wieacker, C. Labarca, C. Fonck, H. A. Lester, and J. Schwarz
Knockin mice with Leu9'Ser {alpha}4-nicotinic receptors: substantia nigra dopaminergic neurons are hypersensitive to agonist and lost postnatally
Physiol Genomics, August 11, 2004; 18(3): 299 - 307.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernan, W. C. Willett, and A. Ascherio
Obesity and the Risk of Parkinson's Disease
Am. J. Epidemiol., March 15, 2004; 159(6): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Ascherio and H. Chen
Caffeinated clues from epidemiology of Parkinson's disease
Neurology, December 9, 2003; 61(90116): S51 - 54.
[Full Text]


Home page
NeurologyHome page
M. F. Allam, C.M. Tanner, S.A. Goldman, D. Aston, R. Ottman, J. Ellenberg, R. Mayeux, and J.W. Langston
Smoking and PD in twins
Neurology, December 10, 2002; 59(11): 1821 - 1822.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Smoking and Parkinson’s disease in twins
Mohamed Farouk Allam
Neurology Online, 17 Jul 2002 [Full text]
Reply to Letter to the Editor
Caroline M. Tanner, et al.
Neurology Online, 17 Jul 2002 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.